HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – HC Wainwright lowered their Q3 2027 earnings per share (EPS) estimates for shares of HIVE Blockchain Technologies in a research report issued on Wednesday, November 11th. HC Wainwright analyst M. Colonnese now anticipates that the company will post earnings per share of ($0.21) for the quarter, down from their previous forecast of ($0.13). HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q4 2027 earnings at ($0.16) EPS, Q1 2028 earnings at ($0.13) EPS, Q2 2028 earnings at ($0.11) EPS, Q3 2028 earnings at ($0.10) EPS, Q4 2028 earnings at ($0.11) EPS and FY2028 earnings at ($0.47) EPS.
Separately, Chardan Capital raised HIVE Blockchain Technologies to a “strong-buy” rating in a report on Monday, July 27th. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, HIVE Blockchain Technologies has an average rating of “Buy”.
Check Out Our Latest Stock Analysis on HIVE Blockchain Technologies
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
Featured Articles
- Five stocks we like better than HIVE Blockchain Technologies
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
